vs
Side-by-side financial comparison of AMBARELLA INC (AMBA) and Immunocore Holdings plc (IMCR). Click either name above to swap in a different company.
AMBARELLA INC is the larger business by last-quarter revenue ($108.5M vs $104.5M, roughly 1.0× Immunocore Holdings plc). On growth, AMBARELLA INC posted the faster year-over-year revenue change (31.2% vs 24.3%). AMBARELLA INC produced more free cash flow last quarter ($31.4M vs $-35.5M). Over the past eight quarters, AMBARELLA INC's revenue compounded faster (45.0% CAGR vs 21.7%).
Ambarella, Inc. is an American fabless semiconductor design company, focusing on low-power, high-definition (HD) and Ultra HD video compression, image processing, and computer vision processors. Ambarella's products are used in a wide variety of human and computer vision applications, including video security, advanced driver assistance systems (ADAS), electronic mirror, drive recorder, driver and in-cabin monitoring, autonomous driving, and robotics applications. Ambarella's system on chips ...
Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.
AMBA vs IMCR — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $108.5M | $104.5M |
| Net Profit | $-15.1M | — |
| Gross Margin | 59.6% | 97.4% |
| Operating Margin | -15.0% | -18.8% |
| Net Margin | -13.9% | — |
| Revenue YoY | 31.2% | 24.3% |
| Net Profit YoY | 37.2% | — |
| EPS (diluted) | $-0.35 | $-0.61 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $108.5M | $104.5M | ||
| Q3 25 | $95.5M | $103.7M | ||
| Q2 25 | $85.9M | $98.0M | ||
| Q1 25 | $84.0M | $93.9M | ||
| Q4 24 | $82.7M | $84.1M | ||
| Q3 24 | $63.7M | $80.2M | ||
| Q2 24 | $54.5M | $75.4M | ||
| Q1 24 | $51.6M | $70.5M |
| Q4 25 | $-15.1M | — | ||
| Q3 25 | $-20.0M | $-177.0K | ||
| Q2 25 | $-24.3M | $-10.3M | ||
| Q1 25 | $-20.2M | $5.0M | ||
| Q4 24 | $-24.1M | — | ||
| Q3 24 | $-34.9M | $8.7M | ||
| Q2 24 | $-37.9M | $-11.6M | ||
| Q1 24 | $-60.6M | $-24.4M |
| Q4 25 | 59.6% | 97.4% | ||
| Q3 25 | 58.9% | 99.5% | ||
| Q2 25 | 60.0% | 98.9% | ||
| Q1 25 | 60.0% | 99.1% | ||
| Q4 24 | 60.6% | 99.6% | ||
| Q3 24 | 60.8% | 99.4% | ||
| Q2 24 | 60.9% | 97.7% | ||
| Q1 24 | 59.8% | 99.7% |
| Q4 25 | -15.0% | -18.8% | ||
| Q3 25 | -23.0% | -6.9% | ||
| Q2 25 | -30.1% | -15.2% | ||
| Q1 25 | -30.2% | -3.9% | ||
| Q4 24 | -30.9% | -23.1% | ||
| Q3 24 | -56.9% | -10.6% | ||
| Q2 24 | -72.4% | -21.2% | ||
| Q1 24 | -80.8% | -37.6% |
| Q4 25 | -13.9% | — | ||
| Q3 25 | -20.9% | -0.2% | ||
| Q2 25 | -28.3% | -10.5% | ||
| Q1 25 | -24.1% | 5.4% | ||
| Q4 24 | -29.1% | — | ||
| Q3 24 | -54.8% | 10.9% | ||
| Q2 24 | -69.6% | -15.4% | ||
| Q1 24 | -117.4% | -34.7% |
| Q4 25 | $-0.35 | $-0.61 | ||
| Q3 25 | $-0.47 | $0.00 | ||
| Q2 25 | $-0.58 | $-0.20 | ||
| Q1 25 | $-0.48 | $0.10 | ||
| Q4 24 | $-0.58 | $-0.47 | ||
| Q3 24 | $-0.85 | $0.17 | ||
| Q2 24 | $-0.93 | $-0.23 | ||
| Q1 24 | $-1.51 | $-0.49 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $174.1M | $864.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $590.1M | $381.0M |
| Total Assets | $751.9M | $1.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $174.1M | $864.2M | ||
| Q3 25 | $142.7M | $892.4M | ||
| Q2 25 | $141.3M | $882.8M | ||
| Q1 25 | $144.6M | $837.0M | ||
| Q4 24 | $127.1M | $820.4M | ||
| Q3 24 | $153.9M | $901.3M | ||
| Q2 24 | $131.8M | $859.6M | ||
| Q1 24 | $144.9M | $832.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $438.7M | ||
| Q2 24 | — | $452.5M | ||
| Q1 24 | — | $452.5M |
| Q4 25 | $590.1M | $381.0M | ||
| Q3 25 | $576.5M | $396.6M | ||
| Q2 25 | $572.7M | $388.5M | ||
| Q1 25 | $561.4M | $378.5M | ||
| Q4 24 | $554.3M | $360.7M | ||
| Q3 24 | $547.6M | $377.8M | ||
| Q2 24 | $555.4M | $359.1M | ||
| Q1 24 | $559.9M | $359.5M |
| Q4 25 | $751.9M | $1.1B | ||
| Q3 25 | $706.4M | $1.1B | ||
| Q2 25 | $701.9M | $1.1B | ||
| Q1 25 | $689.0M | $1.0B | ||
| Q4 24 | $670.8M | $1.0B | ||
| Q3 24 | $650.3M | $1.1B | ||
| Q2 24 | $638.7M | $1.0B | ||
| Q1 24 | $657.7M | $994.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.16× | ||
| Q2 24 | — | 1.26× | ||
| Q1 24 | — | 1.26× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.3M | $-32.7M |
| Free Cash FlowOCF − Capex | $31.4M | $-35.5M |
| FCF MarginFCF / Revenue | 29.0% | -34.0% |
| Capex IntensityCapex / Revenue | 2.7% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $64.3M | $-15.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $34.3M | $-32.7M | ||
| Q3 25 | $5.5M | $-4.5M | ||
| Q2 25 | $14.8M | $26.0M | ||
| Q1 25 | $25.4M | $435.0K | ||
| Q4 24 | $6.6M | $-14.0M | ||
| Q3 24 | $16.7M | $21.1M | ||
| Q2 24 | $-15.0M | $23.5M | ||
| Q1 24 | $-4.0M | $-4.6M |
| Q4 25 | $31.4M | $-35.5M | ||
| Q3 25 | $1.4M | $-5.2M | ||
| Q2 25 | $10.2M | $25.6M | ||
| Q1 25 | $21.2M | $137.0K | ||
| Q4 24 | $4.1M | $-17.5M | ||
| Q3 24 | $14.2M | $20.3M | ||
| Q2 24 | $-16.1M | $23.1M | ||
| Q1 24 | $-6.0M | $-5.0M |
| Q4 25 | 29.0% | -34.0% | ||
| Q3 25 | 1.4% | -5.0% | ||
| Q2 25 | 11.9% | 26.1% | ||
| Q1 25 | 25.3% | 0.1% | ||
| Q4 24 | 5.0% | -20.9% | ||
| Q3 24 | 22.2% | 25.3% | ||
| Q2 24 | -29.5% | 30.7% | ||
| Q1 24 | -11.6% | -7.1% |
| Q4 25 | 2.7% | 2.8% | ||
| Q3 25 | 4.3% | 0.7% | ||
| Q2 25 | 5.3% | 0.4% | ||
| Q1 25 | 5.0% | 0.3% | ||
| Q4 24 | 3.0% | 4.3% | ||
| Q3 24 | 4.0% | 1.0% | ||
| Q2 24 | 2.1% | 0.4% | ||
| Q1 24 | 3.7% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.42× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AMBA
| TW | $76.0M | 70% |
| Asia Pacific Other Than Taiwan | $20.2M | 19% |
| North America Other Than United States | $7.4M | 7% |
| Other | $5.0M | 5% |
IMCR
Segment breakdown not available.
